Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 8 | 2026 | 140 | 4.870 |
Why?
|
| Glioblastoma | 5 | 2026 | 74 | 3.690 |
Why?
|
| Glioma | 7 | 2025 | 96 | 3.680 |
Why?
|
| Blood Platelets | 4 | 2020 | 81 | 2.200 |
Why?
|
| Focal Adhesion Kinase 2 | 6 | 2026 | 15 | 1.520 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 1001 | 1.030 |
Why?
|
| Thrombosis | 2 | 2018 | 81 | 1.010 |
Why?
|
| Indazoles | 1 | 2026 | 12 | 0.970 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 1869 | 0.930 |
Why?
|
| Ploidies | 1 | 2025 | 7 | 0.910 |
Why?
|
| Fluorescent Dyes | 2 | 2025 | 182 | 0.890 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2026 | 159 | 0.870 |
Why?
|
| Neuroblastoma | 1 | 2025 | 136 | 0.830 |
Why?
|
| Astrocytes | 8 | 2019 | 244 | 0.730 |
Why?
|
| Cytochromes c | 2 | 2019 | 48 | 0.720 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 95 | 0.710 |
Why?
|
| Animals | 21 | 2025 | 16992 | 0.660 |
Why?
|
| Amyloidosis | 1 | 2020 | 37 | 0.650 |
Why?
|
| Mice | 10 | 2025 | 6644 | 0.630 |
Why?
|
| Staining and Labeling | 2 | 2025 | 107 | 0.600 |
Why?
|
| Signal Transduction | 3 | 2024 | 2157 | 0.600 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 2676 | 0.580 |
Why?
|
| Parkinson Disease | 1 | 2020 | 210 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 968 | 0.550 |
Why?
|
| Glaucoma | 1 | 2019 | 100 | 0.530 |
Why?
|
| Connexin 43 | 2 | 2017 | 41 | 0.530 |
Why?
|
| Gap Junctions | 2 | 2017 | 49 | 0.530 |
Why?
|
| Antineoplastic Agents | 1 | 2026 | 1019 | 0.530 |
Why?
|
| Peptide Fragments | 1 | 2019 | 307 | 0.510 |
Why?
|
| Skin | 1 | 2018 | 187 | 0.510 |
Why?
|
| Entorhinal Cortex | 1 | 2016 | 11 | 0.510 |
Why?
|
| Polyamines | 1 | 2017 | 32 | 0.510 |
Why?
|
| Brain | 3 | 2020 | 1472 | 0.500 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 43 | 0.490 |
Why?
|
| Visual Cortex | 1 | 2016 | 64 | 0.490 |
Why?
|
| Humans | 17 | 2026 | 43102 | 0.420 |
Why?
|
| Microglia | 1 | 2015 | 208 | 0.390 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 29 | 0.380 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2015 | 64 | 0.340 |
Why?
|
| Neurons | 1 | 2017 | 1263 | 0.310 |
Why?
|
| Male | 6 | 2026 | 23409 | 0.260 |
Why?
|
| Glutamic Acid | 3 | 2015 | 131 | 0.240 |
Why?
|
| Rosaniline Dyes | 1 | 2025 | 5 | 0.240 |
Why?
|
| Boron Compounds | 1 | 2025 | 18 | 0.240 |
Why?
|
| Female | 6 | 2026 | 24698 | 0.230 |
Why?
|
| Spermine | 2 | 2017 | 67 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2026 | 1124 | 0.210 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2024 | 9 | 0.210 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2024 | 16 | 0.210 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2024 | 22 | 0.210 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2024 | 21 | 0.210 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 224 | 0.210 |
Why?
|
| Survival Rate | 1 | 2025 | 355 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 173 | 0.210 |
Why?
|
| Rats | 7 | 2017 | 3735 | 0.200 |
Why?
|
| Embryo Implantation | 1 | 2023 | 31 | 0.200 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1596 | 0.190 |
Why?
|
| Potassium | 4 | 2015 | 109 | 0.190 |
Why?
|
| Sulfonamides | 1 | 2023 | 91 | 0.180 |
Why?
|
| Membrane Potentials | 6 | 2015 | 222 | 0.180 |
Why?
|
| Aged | 2 | 2026 | 8214 | 0.180 |
Why?
|
| Pyridines | 1 | 2023 | 139 | 0.180 |
Why?
|
| Cells, Cultured | 5 | 2019 | 1621 | 0.180 |
Why?
|
| Flow Cytometry | 1 | 2023 | 411 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 386 | 0.180 |
Why?
|
| Infant | 1 | 2025 | 1175 | 0.170 |
Why?
|
| Indoles | 1 | 2023 | 187 | 0.170 |
Why?
|
| Child, Preschool | 1 | 2025 | 1546 | 0.160 |
Why?
|
| Cell Membrane | 3 | 2018 | 403 | 0.160 |
Why?
|
| Cell Survival | 1 | 2023 | 945 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2017 | 388 | 0.160 |
Why?
|
| Middle Aged | 2 | 2026 | 12222 | 0.150 |
Why?
|
| Puerto Rico | 1 | 2024 | 1413 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2020 | 117 | 0.150 |
Why?
|
| Folic Acid | 1 | 2019 | 49 | 0.150 |
Why?
|
| Dermis | 1 | 2018 | 9 | 0.140 |
Why?
|
| Adult | 2 | 2026 | 13872 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2017 | 13 | 0.130 |
Why?
|
| Platelet Count | 1 | 2016 | 13 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 199 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 23 | 0.130 |
Why?
|
| Acidosis | 1 | 2017 | 51 | 0.130 |
Why?
|
| Child | 1 | 2025 | 3443 | 0.130 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 210 | 0.120 |
Why?
|
| Photic Stimulation | 1 | 2016 | 125 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2015 | 536 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2015 | 12 | 0.120 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2015 | 14 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 22 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 189 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 934 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 132 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 290 | 0.110 |
Why?
|
| Calcium | 1 | 2017 | 491 | 0.110 |
Why?
|
| Glucose | 1 | 2015 | 244 | 0.100 |
Why?
|
| Adolescent | 1 | 2025 | 6081 | 0.100 |
Why?
|
| Seizures | 2 | 2010 | 79 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 665 | 0.100 |
Why?
|
| Spermidine | 1 | 2012 | 34 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 35 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 256 | 0.090 |
Why?
|
| Cell Communication | 1 | 2012 | 114 | 0.090 |
Why?
|
| Cell Movement | 1 | 2015 | 655 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 4 | 2015 | 228 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 38 | 0.080 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 13 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2016 | 460 | 0.080 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 82 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1070 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2010 | 80 | 0.080 |
Why?
|
| Quinolines | 1 | 2010 | 78 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 1177 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 456 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 306 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2015 | 352 | 0.040 |
Why?
|
| Barium | 2 | 2010 | 17 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 1766 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 64 | 0.030 |
Why?
|
| Micelles | 1 | 2016 | 36 | 0.030 |
Why?
|
| Neocortex | 1 | 2015 | 27 | 0.030 |
Why?
|
| Colorimetry | 1 | 2015 | 53 | 0.030 |
Why?
|
| Hela Cells | 1 | 2016 | 376 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 75 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 155 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2016 | 174 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 78 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 575 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 277 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 2012 | 26 | 0.020 |
Why?
|
| Carbenoxolone | 1 | 2012 | 10 | 0.020 |
Why?
|
| Giant Cells | 1 | 2012 | 15 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 35 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2012 | 55 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Channelopathies | 1 | 2010 | 5 | 0.020 |
Why?
|
| Ataxia | 1 | 2010 | 8 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1857 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 10 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 73 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 73 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 135 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 267 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 118 | 0.020 |
Why?
|
| Neuroglia | 1 | 2010 | 133 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 115 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 423 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 532 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1568 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1180 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1542 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2007 | 35 | 0.020 |
Why?
|
| Hippocampus | 1 | 2010 | 594 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 876 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1410 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 734 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 863 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 247 | 0.010 |
Why?
|
| Homeostasis | 1 | 2007 | 192 | 0.010 |
Why?
|